Skip to main content

iBio Inc

For the period ended Mar 31, 2025. Filed May 2, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

IBIO$0.80+7.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I. FINANCIAL INFORMATION3
Item 1.Financial Statements:
​Condensed Consolidated Balance Sheets as of March 31, 2025 (unaudited) and June 30, 20243
​Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2025 and 20244
​Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 31, 2025 and 20245
​Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2025 and 20246
​Notes to the Condensed Consolidated Financial Statements8
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations40
Item 3.Quantitative and Qualitative Disclosures About Market Risk54
Item 4.Controls and Procedures54
PART II. OTHER INFORMATION54
Item 1.Legal Proceedings54
Item 1A.Risk Factors55
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds58
Item 3.Defaults Upon Senior Securities58
Item 4.Mine Safety Disclosures58
Item 5.Other Information58
Item 6.Exhibits60
SIGNATURES61
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.